Drawing for PLEASE

USPTO serial 79121608

PLEASE

Reviewed by CopyMark Law Group

Reg. 4489939Status 404
Filing date
Status date
Registration date
Mar 4, 2014
Examiner
STRUCK, ROBERT J
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PLEASE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jacqueline Zion

Jacqueline Zion Pearl Cohen Zedek Latzer, LLP1500 Broadway, 12th FloorNew York, NY 10036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003Non-medicated cosmetics namely, skin, hand, facial, hair, body, non-medicated sunburn and foot lotions and oils, sunscreens, skin gels, lotions and creams for accelerating, enhancing or extending tans, salves, shampoos, body spray, topical skin spray, facial cleanser, personal deodorant and antiperspirant sprays, bath gel, skin moisturizing gel, styling gel, eye gel, dental bleaching gel, and hair gels, facial creams, body creams, cold creams, eye creams, hand creams, night creams, shaving creams, skin cleansing creams, wrinkle vanishing creams, cuticle creams, hair removal creams, hair growth creams, lip creams and nail creams, skin bleaching preparations, anti-ageing preparations and skin depigmentation preparations, topical protectants and skin moisture increasing preparations, skin volume increasing preparations, non-medicated skin preparations containing vitamins, mineral supplements, essential oils; medicated shampoosSECTION 71 - CANCELLED—
005Pharmaceutical preparations for the prevention and treatment of infertility, osteo-Arthritis, pain, menopausal hormone deficiency, primary and secondary amenorrhea, rejection of transplanted organs and limbs, endometriosis, inflammation, thrombosis, psoriasis, Parkinson's disease, diabetes, cancer, multiple sclerosis, allergic conditions, vascular diseases, metabolic diseases, neurological disorders, high risk pregnancy, chronic forms of above mentioned diseases, including vaccines and transdermal drug delivery patches with medication; veterinary preparations for the prevention and treatment of joint injuries; chemical-pharmaceutical preparations for the prevention and treatment of infertility, osteo-Arthritis, pain, menopausal hormone deficiency, primary and secondary amenorrhea, rejection of transplanted organs and limbs, endometriosis, inflammation, thrombosis, psoriasis, Parkinson's disease, diabetes, cancer, multiple sclerosis, allergic conditions, vascular diseases, metabolic diseases, neurological disorders, high risk pregnancy, chronic forms of above mentioned diseases, including vaccines and transdermal drug delivery patches with medication; chemical preparations for pharmaceutical purposes for the prevention and treatment of infertility, osteo-Arthritis, pain, menopausal hormone deficiency, primary and secondary amenorrhea, rejection of transplanted organs and limbs, endometriosis, inflammation, thrombosis, psoriasis, Parkinson's disease, diabetes, cancer, multiple sclerosis, allergic conditions, vascular diseases, metabolic diseases, neurological disorders, high risk pregnancy, chronic forms of above mentioned diseases, including vaccines and transdermal drug delivery patches with medication; chemical preparations for medical purposes for the prevention and treatment of infertility, osteo-Arthritis, pain, menopausal hormone deficiency, primary and secondary amenorrhea, rejection of transplanted organs and limbs, endometriosis, inflammation, thrombosis, psoriasis, Parkinson's disease, diabetes, cancer, multiple sclerosis, allergic conditions, vascular diseases, metabolic diseases, neurological disorders, high risk pregnancy, chronic forms of above mentioned diseases, including vaccines and transdermal drug delivery patches with medication; pharmaceutical preparations and substances for the prevention and treatment of infertility, osteo-Arthritis, pain, menopausal hormone deficiency, primary and secondary amenorrhea, rejection of transplanted organs and limbs, endometriosis, inflammation, thrombosis, psoriasis, Parkinson's disease, diabetes, cancer, multiple sclerosis, allergic conditions, vascular diseases, metabolic diseases, neurological disorders, high risk pregnancy, chronic forms of above mentioned diseases, including vaccines and transdermal drug delivery patches with medication; medicines for human medical purposes for the prevention and treatment of infertility, osteo-Arthritis, pain, menopausal hormone deficiency, primary and secondary amenorrhea, rejection of transplanted organs and limbs, endometriosis, inflammation, thrombosis, psoriasis, Parkinson's disease, diabetes, cancer, multiple sclerosis, allergic conditions, vascular diseases, metabolic diseases, neurological disorders, high risk pregnancy, chronic forms of above mentioned diseases including vaccines and transdermal drug delivery patches with medication; medicines for veterinary purposes for the prevention and treatment of joint injuries; bacteriological and biological preparations for medical or veterinary purposes for the prevention and treatment of infertility, osteo-Arthritis, pain, menopausal hormone deficiency, primary and secondary amenorrhea, rejection of transplanted organs and limbs, endometriosis, inflammation, thrombosis, psoriasis, Parkinson's disease, diabetes, cancer, multiple sclerosis, allergic conditions, vascular diseases, metabolic diseases, neurological disorders, high risk pregnancy, chronic forms of above mentioned diseases including vaccines and transdermal drug delivery patches with medication; bacterial preparations for medical or veterinary purposes; diagnostic agents for medical purposes; adhesive tapes and adhesive strips for medical purposes; plasters for medical purposes; transdermal patches for use in the prevention and treatment of infertility, osteo-Arthritis, pain, menopausal hormone deficiency, primary and secondary amenorrhea, rejection of transplanted organs and limbs, endometriosis, inflammation, thrombosis, psoriasis, Parkinson's disease, diabetes, cancer, multiple sclerosis, allergic conditions, vascular diseases, metabolic diseases, neurological disorders, high risk pregnancy, chronic forms of above mentioned diseases; medicated skin, facial and body care preparations for medical purposes namely, skin lotions and oils, hand lotions and oils, facial lotions and oils, hair lotions and oils, body lotions and oils, sunburn lotions and oils and foot lotions and oils, sunscreens, skin gels, lotions and creams for accelerating, enhancing or extending tans, salves, body sprays, skin sprays and facial sprays, bath gels and cleansers, skin gels and cleansers, eye gels and cleansers and dental gels and cleansers, facial creams, body creams, cold creams, eye creams, hand creams, night creams, shaving creams, skin creams, cleansing creams, wrinkle vanishing creams, cuticle creams, hair removal creams, hair growth creams, lip creams and nail creams, skin bleaching preparations, antiaging preparations, skin depigmentation preparations, topical protectants and acne treatment preparations, skin disease related preparations, skin anomaly and nail anomaly related preparations; acne treatment preparationsSECTION 71 - CANCELLED—
009Scientific, surveying, optical, measuring, signaling, checking and supervision apparatus and instruments, namely, laser not for medical use and waveguides for high power beam delivery; blank magnetic data carriers; blank smart cards; computer software for the operation of or treatment with medical or aesthetic laser, laser devices, energy delivery and energy emitting devices; remote control apparatus in particular for laser devices, robots and optical measuring systems; remote controls with cables or cable-free for laser devices, robots and optical measuring systemsSECTION 71 - CANCELLED—
010Surgical, medical, dental and veterinary instruments and apparatus, namely, lasers for surgical and medical use, and structural parts therefore; medical electrode arrays, disposable tips for medical and surgical laser apparatus, metallic filaments being structural parts of medical electrodes; medical apparatus and instruments, namely, apparatus for ablation and poration of biological tissue by means of radio frequency, heat pulses and laser energy, medical laser apparatus, iontophoresis apparatus in the nature of electromagnetic drug delivery apparatus for medical use, handheld and stationary apparatus for blood glucose monitoring, medical apparatus for cell processing and/or cell cultivating and/or cell storage, inhalers for medical purposes, meter dose inhalers for medical purposes, apparatus for transdermal analyte extraction and their structural parts; apparatus, plasters and containers for the dispensing of medicines, namely, drug delivery systems all sold without medication; transdermal medicine administration apparatus, namely, refillable patches and dry patches without medication; analysis apparatus for medical purposes, namely, blood, cell, substance, molecular analysis or cell separation apparatus, namely, laser based cell separators; medical iontophoretic apparatus and intradermal apparatus, namely, drug delivery systems; medical apparatus for the perforation or for the removal of skin, tissue or organs; diagnostic apparatus for medical purposes; electrodes for medical purposes, namely, electrodes for the ablation and poration of biological tissue, namely, the skin; lasers and laser apparatus for medical purposes; medical lasers and laser apparatus for aesthetic purposes, namely, for removal of port wine stains, removal of warts, removal of old age spots, fine line wrinkle reduction, mid and deep wrinkle reduction, delivery of cosmaceuticals; medical energy delivery and energy emitting devices, namely, electromagnetic radiation apparatus for removal of port wine stains, removal of warts, removal of old age spots, fine line wrinkle reduction, mid and deep wrinkle reduction, delivery of cosmaceuticals; structural parts of medical laser, medical energy delivery and energy emitting devices, for removal of port wine stains, removal of warts, removal of old age spots, fine line wrinkle reduction, mid and deep wrinkle reduction, delivery of cosmaceuticals, namely, monitors, display screens sold as a part of medical equipment, hand pieces, namely, pieces that are connected to the table-top units, tips, used as a hygienic interface between the device and the patient, hand piece tips, used as a hygienic interface between the device and the patient, disposable tips, used as a hygienic interface between the device and the patient; electrodes and cardiac probes for medical purposes; lasers and laser apparatus for medical purposes and for the cosmetic treatment of the face and skin and their structural parts; medical and aesthetic energy delivery or energy emitting devices, their structural parts, namely, electromagnetic medical radiation apparatus; structural parts of medical laser, medical energy delivery and energy emitting devices, namely, computer monitors, computer display screens, handpieces, tips, handpiece tips, disposable tips used in direct association with medical apparatus for the perforation or for the removal of skin, tissue or organs in an individual; special cases for medical instruments, namely, cases fitted for medical instruments and/or for use by doctorsSECTION 71 - CANCELLED—
044Medical and veterinary services; hygienic and beauty care for human beings or animals; medical assistance; plastic surgery; beauty salons; medical clinic servicesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 19, 2022DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Sep 19, 2022DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 26, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 14, 2021INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jul 20, 2021INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jul 20, 2021INPCINVALIDATION PROCESSED—
Jul 12, 2021INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Nov 12, 2020C71TCANCELLED SECTION 71—
Nov 12, 2020APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 4, 2019REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jun 20, 2014FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 4, 2014FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 4, 2014FIMPFINAL DISPOSITION PROCESSED—
Jun 4, 2014FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 4, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 24, 2014ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Oct 11, 2013ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Sep 16, 2013GPNXNOTIFICATION PROCESSED BY IB—
Sep 10, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 10, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 28, 2013OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 28, 2013OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 21, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 8, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 8, 2013ALIEASSIGNED TO LIE—
Jul 26, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 18, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 18, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 18, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 18, 2013ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jul 10, 2013CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 9, 2013CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 17, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 17, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 17, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 8, 2013RFNTREFUSAL PROCESSED BY IB—
Dec 21, 2012MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 19, 2012RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 19, 2012RFRRREFUSAL PROCESSED BY MPU—
Dec 19, 2012RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 18, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 17, 2012DOCKASSIGNED TO EXAMINER—
Dec 17, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 13, 2012REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance